Simultaneous detection, genotyping, and quantification of human papillomaviruses by multicolor real-time PCR and melting curve analysis

Journal of Clinical Microbiology

Volumn 51, Issue 2, 2013, Pages 429-435

  Liao, Yiqun ^a   Zhou, Yulin ^b   Guo, Qiwei ^b   Xie, Xiaoting ^a   Luo, Ena ^a   Li, Jian ^b   Li, Qingge ^a  

^a XIAMEN UNIVERSITY   (China)

^b Maternal and Child Health Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA;

ANALYTIC METHOD; ARTICLE; CANCER GRADING; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC TEST ACCURACY STUDY; GENOTYPING TECHNIQUE; HIGH RESOLUTION MELTING ANALYSIS; HIGH THROUGHPUT SCREENING; HISTOPATHOLOGY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MELTING CURVE ANALYSIS; MULTICOLOR REAL TIME POLYMERASE CHAIN REACTION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS LOAD;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84873023675     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02115-12     Document Type: Article

References (32)

1. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijder PJF, Peto J, Meijer CJLM, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
2. Woodman CBJ, Collins SI, Young LS. 2007. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer 7:11-22.
3. De Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
4. Muñoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518 -527.
5. Roden R, Wu TC. 2006. How will HPV vaccines affect cervical cancer? Nat. Rev. Cancer 6:753-763.
6. Josefsson AM, Magnusson PKE, Ylitalo N, Sørensen P, Qwarforth- Tubbin P, Andersen PK, Melbye M, Adami H, Gyllensten UB. 2000. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355: 2189-2193.
7. Lörincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M. 2002. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360: 228-229.
8. Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. 2003. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int. J. Cancer 103:519 -524.
9. Van Duin M, Snijders PJF, Schrijnemakers HFJ, Voorhorst FJ, Rozendaal L, Nobbenhuis MAE, van den Brule AJC, Verheijen RHM, Merhorst TJ, Meuer CJLM. 2002. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int. J. Cancer 98:590 -595.
10. Molijn A, Kleter B, Quint W, Doorn LJ. 2005. Molecular diagnosis of human papillomavirus (HPV) infections. J. Clin. Virol. 32:43-51.
11. Trofatter KF. 1997. Diagnosis of human papillomavirus genital tract infection. Am. J. Med. 102:21-27.
12. Lörincz AT. 1996. Hybrid Capture™ method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J. Obstet. Gynaecol. Res. 22:629-636.
13. Gravitt P, Peyton C, Apple R, Wheeler C. 1998. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a singlehybridization, reverse line blot detection method. J. Clin. Microbiol. 36: 3020-3027.
14. Kleter B, Van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, Ter Schegget J, Lindeman J, Harmsel BT, Burger M, Quint W. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508 -2517.
15. Liu SS, Leung RCY, Chan KKL, Cheung ANY, Ngan HYS. 2010. Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay. J. Clin. Microbiol. 48:758 -764.
16. Hong SP, Shin SK, Lee EH, Kim EO, Ji SI, Chung HJ, Park SN, Yoo W, Folk WR, Kim S. 2008. High-resolution human papillomavirus genotyping by MALDI-TOF mass spectrometry. Nat. Protoc. 3:1476 -1484.
17. Söderlund-Strand A, Dillner J, Carlson J. 2008. High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry. Clin. Chem. 54:86 -92.
18. Barzon L, Militello V, Lavezzo E, Franchin E, Peta E, Squarzon L, Trevisan M, Pagni S, Bello FD, Toppo S, Palù G. 2011. Human papillomavirus genotyping by 454 next generation sequencing technology. J. Clin. Virol. 52:93-97.
19. Gharizadeh B, Kalantari M, Garcia CA, Johansson B, Nyrén P. 2001. Typing of human papillomavirus by pyrosequencing. Lab. Invest. 81:673- 679.
20. Heideman D, Hesselink A, Berkhof J, van Kemenade F, Melchers W, Daalmeijer NF, Verkuijten M, Meijer CJLM, Snijders PJF. 2011. Clinical validation of the Cobas 4800 HPV test for cervical screening purposes. J. Clin. Microbiol. 49:3983-3985.
21. Cuzick J, Ambroisine L, Cadman L, Austin J, Ho L, Terry G, Liddle S, Dina R, McCarthy J, Buckley H, Bergeron C, Soutter WP, Lyons D, Szarewski A. 2010. Performance of the Abbott real time high-risk HPV test in women with abnormal cervical cytology smears. J. Med. Virol. 82:1186 -1191.
22. Hwang Y, Lee M. 2012. Comparison of the AdvanSure human papillomavirus screening real-time PCR, the Abbott real time high risk human papillomavirus test, and the Hybrid Capture human papillomavirus DNA test for the detection of human papillomavirus. Ann. Lab. Med. 32:201- 205.
23. Micalessi IM, Boulet GA, Bogers JJ, Benoy IH, Depuydt CE. 2012. High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR. Clin. Chem. Lab. Med. 50:655- 661.
24. Huang Q, Liu Z, Liao Y, Chen X, Zhang Y, Li Q. 2011. Multiplex fluorescence melting curve analysis for mutation detection with duallabeled, self-quenched probes. PLoS One 6:e19206. doi:10.1371/journal .pone.0019206.
25. De Roda Husman AM, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. 1995. The use of general primers GP5 and GP6 elongated at their 3= ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76:1057- 1062.
26. Zhou L, Palais RA, Smith GD, Anderson D, Rowe LR, Wittwer CT. 2010. Enrichment and detection of rare alleles by means of snapbackk primers and rapid-cycle PCR. Clin. Chem. 56:814-822.
27. Van den Brule AJ, Meijer CJ, Bakels V, Kenemans P, Walboomers J. 1990. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J. Clin. Microbiol. 28:2739 -2743.
28. Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, Nisenbaum RA, Reeves WC, Icenogle JP. 1999. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 37:1030 -1034.
29. Draper NR, Smith H, Pownell E. 1966. Applied regression analysis, vol 3. John Wiley & Sons, Inc., New York, NY.
30. Bland MJ, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 327:307-310.
31. Lyon E, Millson A, Phan T, Wittwer CT. 1998. Detection and identification of base alterations within the region of factor V Leiden by fluorescent melting curves. Mol. Diagn. 3:203-210.
32. Lay MJ, Wittwer CT. 1997. Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR. Clin. Chem. 43:2262-2267.